Skip to content
Clinical research in Latin America
  • About Cohortias
    • Commitment
    • Our Story
    • Team
    • Why Latin America
  • Careers
  • Cohortias – Clinical Research in Latin America
  • Cohortias – Investigación Clínica en América Latina
    • Contacto
    • Nosotros
      • Compromiso
      • Equipo de Investigación Clínica
      • Historia
      • Investigación Clínica en América Latina
    • Recursos de Investigación Clínica
      • Noticias de Estudios Clínicos: Actualizaciones de COVID-19 (Coronavirus)
      • Oportunidades Laborales
      • Rigor Científico en Investigación Clínica
    • Servicios de Investigación Clínica
      • Dispositivos Médicos
      • Ensayos Clínicos de Primeras Fases
      • Estudios Clínicos Fase II y III
      • Estudios de Rescate
  • Contact
  • Insights
    • Clinical Research News
    • Events
    • Our Science
  • Join Us
    • Registration
    • Registration
  • Member Login
    • Password Reset
    • Password Reset
    • Profile
    • Profile
  • Members
  • Privacy
  • Privacy Policy
  • Services
    • Early Phase Trials
    • Medical Devices
    • Phase II & III Trials
    • Rescue Studies
  • Sites and Network
  • Trials
    • Argentina
      • Alecardio Argentina
      • Other Studies – Argentina
      • Spire I & II Argentina
    • Brazil
      • Alecardio Brazil
      • Other Studies – Brazil
      • Spire I & II Brazil
    • Colombia
      • Alecardio Colombia
      • Spire I & II Colombia
    • Mexico
      • Alecardio Mexico
      • Spire I & II Mexico
  • Cohortias Blog

    1. Home>
    2. Cohortias Blog
    Read more about the article Cohortias – Positive data from Alzheimer’s disease vaccine trial

    Cohortias – Positive data from Alzheimer’s disease vaccine trial

    • Post author:quickappsmkt
    • Post published:January 27, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    At week six, the ACI-24.060 vaccine elicited an anti-Abeta antibody response in ABATE’s first, low dose cohort of AD patients.

    Continue ReadingCohortias – Positive data from Alzheimer’s disease vaccine trial
    Read more about the article Cohortias – Phase I for new ulcerative colitis therapy trial

    Cohortias – Phase I for new ulcerative colitis therapy trial

    • Post author:quickappsmkt
    • Post published:January 26, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    ALTB-268 helps to restore the immune system to a state of balance.

    Continue ReadingCohortias – Phase I for new ulcerative colitis therapy trial
    Read more about the article Cohortias – FDA clears to begin colorectal cancer therapy trial

    Cohortias – FDA clears to begin colorectal cancer therapy trial

    • Post author:quickappsmkt
    • Post published:January 24, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    The trial will enroll 44 patients who are failing prior lines of chemotherapy and who express LGR5 on cancer cells.

    Continue ReadingCohortias – FDA clears to begin colorectal cancer therapy trial
    Read more about the article Cohortias – New trial for lung disease treatment

    Cohortias – New trial for lung disease treatment

    • Post author:quickappsmkt
    • Post published:January 20, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    The trial will assess the efficacy and safety of pulsed inhaled nitric oxide in patients at risk for pulmonary hypertension.

    Continue ReadingCohortias – New trial for lung disease treatment
    Read more about the article Cohortias – Phase II trial of nasal spray therapy for Hyposmia

    Cohortias – Phase II trial of nasal spray therapy for Hyposmia

    • Post author:quickappsmkt
    • Post published:January 19, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    The trial is expected to enroll subjects at 20 clinical sites in the US and will assess CYR-064 for six months.

    Continue ReadingCohortias – Phase II trial of nasal spray therapy for Hyposmia
    Read more about the article Cohortias – When will the new vaccine to prevent herpes zoster be available in Argentina?

    Cohortias – When will the new vaccine to prevent herpes zoster be available in Argentina?

    • Post author:quickappsmkt
    • Post published:January 18, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    Shingrix shingles vaccine was 90% effective in preventing viral infection in adults over 50 years of age

    Continue ReadingCohortias – When will the new vaccine to prevent herpes zoster be available in Argentina?
    Read more about the article Cohortias – ‘Incurable’ Fatal Syndrome May Finally Be Treated By New Drug

    Cohortias – ‘Incurable’ Fatal Syndrome May Finally Be Treated By New Drug

    • Post author:quickappsmkt
    • Post published:January 16, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    At the moment there's no known cure for it, but scientists have now identified a potentially effective treatment

    Continue ReadingCohortias – ‘Incurable’ Fatal Syndrome May Finally Be Treated By New Drug
    Read more about the article Cohortias – First data report from study of rare prostate cancer therapy

    Cohortias – First data report from study of rare prostate cancer therapy

    • Post author:quickappsmkt
    • Post published:January 13, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    The trial assessed the efficacy and safety of BXCL701 along with pembrolizumab in SCNC patients.

    Continue ReadingCohortias – First data report from study of rare prostate cancer therapy
    Read more about the article Cohortias – Mexican pharma market growth factors and advantages

    Cohortias – Mexican pharma market growth factors and advantages

    • Post author:quickappsmkt
    • Post published:January 12, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    Global pharma companies are turning their focus to Mexico, with its low manufacturing costs and proximity to the US as two of the major advantages.

    Continue ReadingCohortias – Mexican pharma market growth factors and advantages
    Read more about the article Cohortias – Anvisa analyzes application for registration of dengue vaccine

    Cohortias – Anvisa analyzes application for registration of dengue vaccine

    • Post author:quickappsmkt
    • Post published:January 10, 2023
    • Post category:Cohortias Blog
    • Post comments:0 Comments

    The purpose of the meeting is to clarify technical doubts and have access to preliminary data.

    Continue ReadingCohortias – Anvisa analyzes application for registration of dengue vaccine
    • 1
    • 2
    • 3
    • 4
    • …
    • 45
    • Go to the next page